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Background:  Propofol and remifentanil are used for tracheal intubation in the absence of neuromuscular blocking 
agents.  We hypothesized that the addition of sevoflurane to propofol and remifentanil would improve intubation 
conditions and provide hemodynamic stability.
Methods:  Seventy-six patients scheduled for elective surgery were randomly allocated to be ventilated with either 4% 
(group I) or 7% sevoflurane (group II) after propofol injection (2 mg/kg).  All patients received remifentanil (1 μg/kg) 
30 seconds after administration of propofol.  Ninety seconds after remifentanil was given, laryngoscopy and tracheal 
intubation were performed. Intubation conditions and hemodynamic changes were evaluated. 
Results:  The overall incidence of clinically acceptable intubation conditions was significantly higher in group II (92%) 
than group I (58%) (P = 0.001).  Scores for vocal cord position, coughing, and limb movement were significantly better 
in group II (P < 0.05).  Mean blood pressure remained significantly lower than the pre-induction level throughout 
the investigation in both groups (P < 0.001), but there was no incidence of bradycardia or hypotension requiring 
treatment. 
Conclusions:  Tracheal intubation without neuromuscular blocking agents can be achieved safely and reliably by 
adding 7% sevoflurane to propofol (2 mg/kg) and remifentanil (1 μg/kg).   (Korean J Anesthesiol 2010; 59: 87-91)
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Introduction
    Although tracheal intubation is facilitated by muscle relaxants, 
neuromuscular blocking agents may be contraindicated (e.g., 
in patients with known allergic reactions or myopathies) 
or associated with side effects such as prolonged paralysis, 
awareness, or complications of residual neuromuscular 
blockade. This has led to intubation without neuromuscular 
blocking agents (IWNA). Ambulatory anesthesia requires 
a rapid, safe recovery of spontaneous breathing. IWNA is 
also useful for short duration anesthesia when intubation is 
necessary but neuromuscular blockage is not. 
    Optimal combinations of hypnotic agents and opioids should 
provide satisfactory intubation conditions without neuro  muscular 
blockade. Propofol produces superior relaxation of the jaw 
[1,2] and suppression of airway reflexes compared with other 
intravenous induction agents [3,4], whereas remifentanil is an 
ultra-short acting opioid with rapid onset and strong potency, 
making it ideal for short noxious stimulation such as intubation. 
Thus, various combinations of propofol and remifentanil 
have been proposed for IWNA [5-10]. Sevoflurane, a non-
irritating inhaled anesthetic agent with low blood gas solubility, 
has also been used for IWNA, either alone or combined 
with remifentanil [11-14]. In the absence of neuromuscular 
blocking agents, however, a relatively large dose of propofol 
or remifentanil and a high concentration of sevoflurane are 
required for longer durations, which may lead to hemodynamic 
instability [8-11].
    We hypothesized that the addition of sevoflurane to propofol 
and remifentanil would allow the use of lower doses of 
propofol and remifentanil as well as reduce the incidence of 
hemodynamic instability. To date, there have been no studies 
on intubation conditions using balanced administration 
of propofol, remifentanil, and sevoflurane. We therefore 
investigated the effects of sevoflurane combined with propofol 
(2 mg/kg) and remifentanil (1 μg/kg) on intubation conditions 
and hemodynamic responses in the absence of neuromuscular 
blocking agents.
Materials and Methods 
    This study was approved by our institutional review board 
and informed written consent was obtained from patients. 
We studied 76 American Society of Anesthesiologist Physical 
Status I patients, aged 16-60 years, undergoing elective 
surgery under general anesthesia requiring tracheal intubation. 
Exclusion criteria included a history of drug or alcohol abuse, 
upper gastrointestinal reflux, cardiovascular disease or reactive 
airway diseases, including smoking, body mass index 30 or 
more, allergies to any of the study drugs, administration of 
sedative or narcotic drugs in the previous 24 h, renal or hepatic 
impairment, or a Mallampati classification of airway anatomy 
above class II.
    Automated non-invasive arterial pressure (NIBP), electro-
cardiogram, pulse oximetry (SpO2), and end tidal carbon dioxide 
concentrations (ETCO2) were monitored in the anesthetic room. 
All patients were prehydrated with balanced salt solution (5 ml/
kg). Midazolam (0.03 mg/kg) and glycopyrrolate (0.2 mg) were 
administered intravenously (IV) approximately 5 min before 
anesthesia.
    Patients were allocated randomly to receive 4% (group I) or 
7% sevoflurane (group II), based on the results of a small pilot 
study, with assignment decided using sealed envelopes. After 3 
min of pre-oxygenation, anesthesia was induced with propofol 
(2 mg/kg) over 30 s using a hand-held syringe. To reduce pain 
on injection, lidocaine (10 mg) was added to each 100 mg of 
propofol. Once a patient lost consciousness, mask ventilation 
was gently initiated with the predetermined concentration of 
sevoflurane in 100% oxygen, 4 L, to keep the ETCO2 between 
25-30 mmHg until intubation was attempted.
    Thirty seconds after administration of propofol, remifentanil 
(1 μg/kg) was infused over 30 s. Remifentanil was made up 
to a volume of 10 ml in 0.9% saline. Ninety seconds later, an 
experienced anesthesiologist unaware of the concentration 
of sevoflurane employed attempted tracheal intubation by 
laryngoscope using a Macintosh 3 laryngoscope blade. Each 
trachea was intubated with a cuffed endotracheal tube (7.0 mm 
for women or 8.0 mm for men), followed by slow inflation of 
the cuff over the next 5 s. End-tidal sevoflurane concentration 
was measured using a Datex anesthesia gas monitor (IntelliVue 
MP70, Philips, USA) immediately before tracheal intubation. If 
any difficulty was encountered in performing mask ventilation 
following induction of anesthesia, or if the intubation was 
not completed within 30 s, the patient was withdrawn from 
the study and was given neuromuscular blocking agent 
for intubation. After intubation, mechanical ventilation 
with a mixture of oxygen and air was initiated to maintain 
normocapnia and no further stimulation was applied to the 
patient. 
    Intubation conditions were assessed for five variables (jaw 
relaxation, ease of laryngoscopy, position of the vocal cords, 
and patient response to intubation and cuff inflation) and 
scored using a modification of a previous scoring system by 
another investigator who was blinded to the protocol (Table 1) 
[15]. Intubation conditions were considered acceptable if all 
scores were 2 or less and unacceptable if any score was 3. In 
both groups, mean arterial blood pressure (MBP), heart rate 
(HR), and SpO2 were measured prior to induction of anesthesia 
(T0, pre-induction, baseline), just after propofol (T1) and 
remifentanil (T2, pre-intubation) infusion, and every minute 89 www.ekja.org
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after tracheal intubation for 3 min (T3-5). 
    Patients who could not be intubated within 30 s during the 
first attempt and who coughed persistently after tracheal 
intubation were given an IV dose of rocuronium and no 
further data were recorded. The occurrence of laryngospasm, 
bronchospasm, chest rigidity, hypotension, and bradycardia 
were recorded. Bradycardia was defined as HR < 50 beats per 
min and hypotension was defined as MBP < 50 mmHg.
    Prior to initiation of the study, a power analysis was 
performed. A preliminary study of 15 consecutive patients given 
4% sevoflurane showed acceptable intubation in 60%. Thus, 
a minimum of 38 patients per group was required to detect 
an increase from 60% to 90% in the proportion of those with 
acceptable intubation conditions with a power of 80% and a 
significance level of 95%.
    Data are expressed as means ± SD or as numbers of patients. 
Differences between groups were analyzed using an unpaired 
t-test or Mann-Whitney U-test. Proportions were analyzed 
using Chi-square test or Fisher’s exact test, as appropriate. 
Hemodynamic variables within groups were analyzed using 
Friedman repeated measures analysis of variance on ranks, 
followed by Student-Newman-Keuls methods. SigmaStat 
3.1 (Systat software Inc., Chicago, IL) was used for statistical 
analysis and P < 0.05 was considered to be statistically 
significant.
Results
    A total of 76 patients were enrolled in this study. Two patients 
in each group were withdrawn because of unexpectedly difficult 
intubation or no visualization of vocal cords, and replaced by 
an additional 4 patients. There were no significant differences 
between the two groups in terms of age, weight, and gender 
ratios (Table 2). The mean end-tidal sevoflurane concentration 
just before intubation was significantly higher in group II (2.9%) 
than in group I (1.7%) (P < 0.001).
    The overall incidence of clinically acceptable intubation 
conditions was significantly higher in group II (92%) than group 
I (58%) (P = 0.001) (Table 3). Excellent intubation conditions 
(score of 1 in all categories) were achieved more often in group 
II (20/38 patients, 53%) than those in group I (13/38 patients, 
34%). Although there was no failed intubation in group II, 
tracheal intubation failed in two patients of group I because of 
poor jaw relaxation or closed vocal cords. Three patients in the 
group I required rocuronium because of failed intubation and 
persistent coughing. Scores for vocal cord position, coughing, 
Table 1. Intubation Scores 
Score 
Intubation conditions
                                                Acceptable Unacceptable
1 2 3
Jaw relaxation
Laryngoscopy
Vocal cords 
Coughing
Limb movement
Relaxed 
Easy 
Abducted 
None 
None 
Acceptable relaxation
Fair 
Intermediate
Diaphragmatic 
Slight 
Poor relaxation
Difficult 
Closed 
Severe coughing or bucking 
Vigorous 
Excellent: all criteria are score 1, Good: all criteria are either a score 1 or 2, Poor: the presence of a single criterion rated as a score 3. Excellent 
and good intubation conditions are considered clinically acceptable, whereas poor intubation conditions are not.
Table 2. Subject Demographics
Group I
(n = 38)
Group II
 (n = 38)
Age (yr)
Weight (kg)
Gender (M/F)
Et  sevoflurane 
  before intubation (vol%)
37.6 (16-53)
56.5 ± 7.6
5 / 33
1.7 ± 0.2
34.8 (17-58)
57.8 ± 8.0
6 / 32
2.9 ± 0.3*
Values are expressed as mean ± SD or (range) or number. Et 
sevoflurane: end-tidal sevoflurane concentration. *P < 0.05 
compared with the group I.
Table 3. Number of Patients in Each Group 
  Group I Group II
Intubating conditions*
    Excellent*
    Good
    Poor
Jaw relaxation
    Score 1/2/3
Laryngoscopy
    Score 1/2/3
Vocal cords*
    Score 1/2/3
Coughing*
    Score 1/2/3
Limb movements*
    Score 1/2/3
13
  9
16
35/1/2
35/1/2
24/12/1
13/10/13
24/10/2
20
15
  3
38/0/0
38/0/0
35/3/0
20/15/3
36/2/0
Values are expressed as number of patients. *P < 0.05 compared with 
the group I.90 www.ekja.org
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and limb movement were significantly lower in group II than 
those in group I (Table 3) (P < 0.05), but not scores for jaw 
relaxation or ease of laryngoscope (P > 0.05). 
    Before induction, pre-induction MBP and HR were not signi-
ficantly different between groups (P > 0.05) (Fig. 1 and 2). MBP 
remained significantly lower than the pre-induction level in 
both groups (P < 0.001). HR was unchanged or lower compared 
with pre-induction levels in both groups, but MBP and HR were 
not different at any time (P > 0.05). There was no episode of 
opioid-induced muscle rigidity, bradycardia, or hypo  tension 
requiring treatment and no other side effects were seen. SpO2 
remained at the pre-induction levels, 97-100%, in all patients.
Discussion 
    We have shown here that the addition of 7% sevoflurane to 
propofol (2 mg/kg) and remifentanil (1 μg/kg) reliably provided 
acceptable conditions for IWNA. The addition of 7% sevoflurane 
produced significantly better intubation conditions than 4% 
sevoflurane and was not associated with any incidence of failed 
intubation. In addition, the position of the vocal cords was more 
favorable and the degree of coughing and limb movements 
following intubation lower in patients given 7% sevoflurane, 
probably due to a deeper level of anesthesia.
    The use of sevoflurane for induction and tracheal intubation 
has been widely investigated in children and adults. However, 
the end-tidal sevoflurane concentration required for tracheal 
intubation was high (ED95 = 8.07%) and the time required 
to reach an adequate depth of anesthesia in adults using 
sevoflurane alone was over 6 min [12,16]. A bolus or continuous 
infusion of remifentanil after sevoflurane induction facilitated 
IWNA [11-14]. Joo et al. [11] showed that the addition of 
remifentanil (2 μg/kg) after induction with 8% sevoflurane 
and 50% nitrous oxide provided optimal intubation conditions 
in all patients within 3 min. However, the combined use of 
sevoflurane with high-dose remifentanil was associated with 
hypotension in 29% of patients. 
    The beneficial effects of our method include, in the majority 
of patients, acceptable intubation conditions without 
neuromuscular blocking agents, within 3 min, and without 
hemodynamic compromise. The high incidence of acceptable 
intubation conditions was comparable with that seen in the 
60-100% of patients treated by propofol/remifentanil tracheal 
intubation without neuromuscular blocking agents [5-10]. 
These earlier studies, however, used larger doses of propofol 
or remifentanil to obtain optimal intubation conditions, with 
occasional development of hypotension [8-10]. The addition of 
sevoflurane at the induction of anesthesia enabled the use of 
lower doses propofol and remifentanil to achieve comparable 
results. We selected a propofol dose of 2 mg/kg because this 
dose is frequently recommended for anesthesia induction 
in adults. The remifentanil dose of 2-5 μg/kg was employed 
because it produces adequate conditions for IWNA when 
combined with propofol (2 mg/kg) in pre-medicated healthy 
adults [6-10]. As remifentanil may cause muscle rigidity in 
proportion to dose and rate of administration [17], we choose a 
lower dose of remifentanil (1 μg/kg) and infused the drug over 30 s.
    The timing of drug administration was crucial to the high 
success rate of IWNA achieved in this report. When the peak 
site effects of propofol and remifentanil occur simultaneously, 
optimal intubation conditions are attained [18]. The peak effect 
of remifentanil occurred approximately 90 s after a bolus dose 
[19], and the propofol effect peaks 180 s after administration 
[20]. We therefore timed the administration of these drugs 
to synchronize peak site effects at the time of intubation, 
and hypothesized that the addition of sevoflurane between 
induction of anesthesia and intubation would provide better 
intubation conditions. 
Fig. 1. Changes in mean blood pressure during the study. Data are 
presented as mean ± SD. T0: before induction, T1: after propofol 
infusion, T2: after remifentanil infusion, T3-5: every 1 min after 
intubation for 3 min. *P < 0.05 when compared with T0.
Fig. 2. Changes in heart rate during the study. Data are presented 
as mean ± SD. T0: before induction, T1: after propofol infusion, T2: 
after remifentanil infusion, T3-5: every 1 min after intubation for 3 
min. *P < 0.05 when compared with T0.91 www.ekja.org
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    The balanced use of propofol, remifentanil, and sevoflurane 
made it possible to avoid hemodymamic depression, which 
has been noted when large doses of one or two agents [8-11]. 
MBP was lower at all time points than the pre-induction level, 
but no patient developed hypotension requiring treatment. 
Glycopyrrolate was administrated as an anti-sialogue and 
as prophylaxis against bradycardia, and clinically significant 
bradycardia was not encountered. As our method attenuated 
the hemodynamic response to tracheal intubation in all 
patients, the approach may be useful when prevention of 
cardiovascular intubation response is required, without the 
use of large doses of opioids or adjunctive cardiovascular 
depressant agents. 
    Our study has several limitations. First, it is important to 
consider patient demographic characteristics, such as gender 
and age, prior to use of this method. Gender differences 
can affect the pharmacodynamics and pharmacokinetics of 
propofol [21], and women have significantly higher propofol 
serum concentrations at the point of loss of consciousness [22]. 
In addition, older patients are more sensitive to opioids than 
younger ones. Our study population showed a predominance 
of young females, which should be considered when inter-
preting our data. Second, the decreases in MBP and HR were 
well tolerated by the healthy, well-hydrated patients of our 
study. However, this method cannot be recommended for 
hypovolemic or debilitated patients. Another limitation was 
the failure to include a control group (receiving only propofol 
and remifentanil without sevoflurane) in this study design. 
In a small pilot study, the IWNA with propofol (2 mg/kg) and 
remifentanil (1 μg/kg) failed in four successive patients. Thus, 
for ethical reasons, we could not include a control group.
    In conclusion, our results suggest that the addition of 7% 
sevoflurane to timely injections of low dose propofol (2 mg/
kg) and remifentanil (1 μg/kg) provides satisfactory intubation 
conditions without hemodynamic compromise in healthy 
premedicated patients with favorable airway anatomy. This 
method may be appropriate when tracheal intubation is 
necessary but neuromuscular blockade is not desired. 
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